Breaking News

Financial Report: Thermo Fisher Scientific

January 31, 2013

Revenues up 6% in the quarter

Thermo Fisher Scientific

4Q Revenues: $3.3 billion (+6%)

4Q Earnings: $376.4 million (+12%)

FY Revenues: $12.5 billion (+8%)

FY Earnings: $1.2 billion (+9%)

Comments: Analytical Technologies Segment revenue was up 2% to $1.1 billion in the quarter. Specialty Diagnostics Segment revenue increased 12% to $792 million. Laboratory Products and Services Segment revenue increased 4% to $1.5 billion.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks